Great news in treatment for Alzheimer's! Drug maker Biogen says early results showed that their treatment, lecanemab, reduced patient clinical decline by 27% when compared to a placebo or fake drug after 18 months of the infused treatment. Patients were monitored using a scale that measures memory, judgement, problem solving and personal care. For more details on this story, click on link below: